Irish biomaterials company sold to Ashland for $12m

23rd December, 2018
Sean McMahon

An Irish company that develops biomaterial solutions for the pharma and medical devices sector has been sold for $12 million to global chemical company Ashland.

Vornia produces a range of medical biomaterials for the pharmaceutical, cosmetic and medical devices industry, as well as for academic and industrial clients. Biomaterials are biological or synthetic substances which can be introduced into body tissue. Vornia’s biomaterial platform technologies can be applied in 3D bioprinting, drug and gene delivery and...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Analysis: Financial and political hurdles could block European Super League

Sport Emmet Ryan 18 hours ago

Emer McLysaght: Dazed and confused in a new age of A&E

Nadine O’Regan: Will the pandemic finally deliver a revolution in comfort dressing?

Brian Keegan: A solidarity tax would be a step backwards

Tax Brian Keegan 2 days ago